MX9605979A - Uso novedoso de peptidos de gluten como estimulantes de absorcion de minerales y como agentes preventivos de hiperlipidemia e hipercolesterolemia. - Google Patents
Uso novedoso de peptidos de gluten como estimulantes de absorcion de minerales y como agentes preventivos de hiperlipidemia e hipercolesterolemia.Info
- Publication number
- MX9605979A MX9605979A MX9605979A MX9605979A MX9605979A MX 9605979 A MX9605979 A MX 9605979A MX 9605979 A MX9605979 A MX 9605979A MX 9605979 A MX9605979 A MX 9605979A MX 9605979 A MX9605979 A MX 9605979A
- Authority
- MX
- Mexico
- Prior art keywords
- stimulator
- absorption
- mineral absorption
- active ingredient
- calcium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invencion se refiere al uso novedoso de péptidos de gluten como un estimulante de absorcion de minerales, y como un agente preventivo de la hiperlipidemia e hipercolesterolemia inducidas por la grasa dietética. Los péptidos de gluten se preparan mediante la hidrolisis enzimática de proteínas vegetales, que tiene un peso molecular de 200 a 600 daltons, y que comprenden el 20 por ciento molar o más de aminoácidos ácidos. Los péptidos de gluten se pueden utilizar para el desarrollo de un estimulante de la absorcion intestinal de calcio y hierro, y como un agente preventivo de la hiperlipidemia e hipercolesterolemia inducidas por la grasa dietética en una forma de material alimenticio.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960004070A KR100194074B1 (ko) | 1996-02-21 | 1996-02-21 | 글루텐 펩타이드를 유효성분으로 포함하는 미네랄 흡수 촉진제 |
KR1019960004070 | 1996-02-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
MXPA96005979A MXPA96005979A (es) | 1998-04-01 |
MX9605979A true MX9605979A (es) | 1998-04-30 |
Family
ID=19451488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9605979A MX9605979A (es) | 1996-02-21 | 1996-11-29 | Uso novedoso de peptidos de gluten como estimulantes de absorcion de minerales y como agentes preventivos de hiperlipidemia e hipercolesterolemia. |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0791357A3 (es) |
KR (1) | KR100194074B1 (es) |
MX (1) | MX9605979A (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI351278B (en) * | 2002-03-01 | 2011-11-01 | Nisshin Pharma Inc | Agent for preventing and treating of liver disease |
US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
KR102503474B1 (ko) * | 2020-04-29 | 2023-02-28 | 주식회사 대호 | 가축용 성장촉진제 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4167564A (en) * | 1974-09-23 | 1979-09-11 | Albion Laboratories, Inc. | Biological assimilation of metals |
CA1335567C (en) * | 1988-02-02 | 1995-05-16 | Kyoichi Kagawa | Lipid metabolism promoting agent |
JP3195937B2 (ja) * | 1992-04-22 | 2001-08-06 | 日清製粉株式会社 | アミラーゼ阻害物質の取得方法 |
-
1996
- 1996-02-21 KR KR1019960004070A patent/KR100194074B1/ko not_active IP Right Cessation
- 1996-10-09 EP EP96307351A patent/EP0791357A3/en not_active Withdrawn
- 1996-11-29 MX MX9605979A patent/MX9605979A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP0791357A3 (en) | 1998-10-28 |
EP0791357A2 (en) | 1997-08-27 |
KR970061268A (ko) | 1997-09-12 |
KR100194074B1 (ko) | 1999-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2259163A1 (en) | Nt-3 and bdnf analogs having improved circulating life and/or absorption | |
EP2112161A3 (en) | Peptides that lower blood glucose levels | |
DE69630779D1 (de) | Therapeutische verwendungen von glucan | |
WO2003093314A3 (en) | Connective tissue stimulating peptides | |
BR0109027A (pt) | Peptìdios derivados de caseìna e usos dos mesmos em terapia | |
CA2158058A1 (en) | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof | |
FR2792202B1 (fr) | Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait | |
WO2003037932A3 (en) | Human coagulation factor vii polypeptides | |
MX9605979A (es) | Uso novedoso de peptidos de gluten como estimulantes de absorcion de minerales y como agentes preventivos de hiperlipidemia e hipercolesterolemia. | |
NZ333724A (en) | Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions | |
MY125875A (en) | Method and food product for increasing muscle protein and reducing fat in animals | |
WO1996028470A3 (en) | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis | |
BG104266A (en) | Aminoterminally incised mcp-2 as haemokin antagonists | |
HU9700826D0 (en) | Pharmaceutical compositions against peptic ulcer | |
PL349490A1 (en) | Baby food stimulating growth of the thymus | |
IT1187828B (it) | Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi | |
EP0791601A3 (en) | An agent promoting bone formation and inhibiting bone resorption | |
WO2000075173A3 (en) | Peptide fragments of colostrinin | |
HUT66309A (en) | Bpc peptides, their preparation and therapeutic use | |
AU1384995A (en) | Human circulating cytokine cc-1 | |
ATE320270T1 (de) | Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren | |
BR0212625A (pt) | peptìdeos derivados de caseìna e usos dos mesmos em terapia | |
CA2157506A1 (en) | Osteogenic growth oligopeptides and pharmaceutical compositions containing them | |
BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
NZ332690A (en) | Stimulation of host defence mechanisms against viral challenges using interferon |